70 research outputs found

    Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients

    Get PDF
    to determine the emergence and evolution of DRAM during LLV in HIV-1-infected patients while receiving antiretroviral therapy (ART).Retrospective analysis of patients presenting a LLV episode defined as pVL between 40 and 500 c/mL on at least 3 occasions during a 6-month period or longer while on the same ART. Resistance genotypic testing was performed at the onset and at the end of LLV period. Emerging DRAM was defined during LLV if never detected on baseline genotype or before.48 patients including 4 naive and 44 pretreated (median 9 years) presented a LLV episode with a median duration of 11 months. Current ART included 2NRTI (94%), ritonavir-boosted PI (94%), NNRTI (23%), and/or raltegravir (19%). Median pVL during LLV was 134 c/mL. Successful resistance testing at both onset and end of the LLV episode were obtained for 37 patients (77%), among who 11 (30%) acquired at least 1 DRAM during the LLV period: for NRTI in 6, for NNRTI in 1, for PI in 4, and for raltegravir in 2. During the LLV period, number of drugs with genotypic resistance increased from a median of 4.5 to 6 drugs. Duration and pVL level of LLV episode, duration of previous ART, current and nadir CD4 count, number of baseline DRAM and GSS were not identified as predictive factors of resistance acquisition during LLV, probably due to limited number of patients.Persistent LLV episodes below 500 c/ml while receiving ART is associated with emerging DRAM for all drug classes and a decreasing in further therapeutic options, suggesting to earlier consider resistance monitoring and ART optimization in this setting

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

    Get PDF
    Background: The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms. Methods: International, prospective observational study of 60 109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms. Results: ‘Typical’ symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (≀ 18 years: 69, 48, 23; 85%), older adults (≄ 70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each P < 0.001). The most common atypical presentations under 60 years of age were nausea and vomiting and abdominal pain, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country. Interpretation: This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men

    Un Nouveau Dispositif de RĂ©Ă©ducation dans l’Univers des Troubles « Dys » : S’TIM, le Serious-Game Persuasif ThĂ©rapeutique Conçu pour les Patients DysexĂ©cutifs

    No full text
    Dans l’univers des troubles «dys», les personnes atteintes de troubles dysexĂ©cutifs sont en attente de nouvelles solutions pour leur rĂ©Ă©ducation. A partir d’une analyse approfondie de la littĂ©rature, un consortium multidisciplinaire a Ă©tĂ© crĂ©Ă© afin de spĂ©cifier et de dĂ©velopper un Serious-Game qui immerge les patients dans un monde virtuel Ă  travers un scĂ©nario Ă©laborĂ© et des missions variĂ©es. Il s’utilise sur une table tactile robotisĂ©e de 48’ facile Ă  apprĂ©hender. Ce dispositif a trois enjeux majeurs. Tout d’abord la levĂ©e de l’anosognosie ainsi que le passage Ă  une motivation intrinsĂšque des patients afin qu’ils soient acteurs de leur rĂ©Ă©ducation. Ensuite, l’atteinte d’une mĂ©tacognition suffisante pour qu’ils puissent dĂ©velopper des stratĂ©gies qui leurs sont propres et qu’ils sĂ©lectionnent la plus appropriĂ©e dans chaque contexte. Enfin, la facilitation du transfert de ces stratĂ©gies dans la vie quotidienne. Des changements dans l’organisation des thĂ©rapeutes sont Ă©galement attendus

    Un Nouveau Dispositif de RĂ©Ă©ducation dans l’Univers des Troubles « Dys » : S’TIM, le Serious-Game Persuasif ThĂ©rapeutique Conçu pour les Patients DysexĂ©cutifs

    No full text
    Dans l’univers des troubles «dys», les personnes atteintes de troubles dysexĂ©cutifs sont en attente de nouvelles solutions pour leur rĂ©Ă©ducation. A partir d’une analyse approfondie de la littĂ©rature, un consortium multidisciplinaire a Ă©tĂ© crĂ©Ă© afin de spĂ©cifier et de dĂ©velopper un Serious-Game qui immerge les patients dans un monde virtuel Ă  travers un scĂ©nario Ă©laborĂ© et des missions variĂ©es. Il s’utilise sur une table tactile robotisĂ©e de 48’ facile Ă  apprĂ©hender. Ce dispositif a trois enjeux majeurs. Tout d’abord la levĂ©e de l’anosognosie ainsi que le passage Ă  une motivation intrinsĂšque des patients afin qu’ils soient acteurs de leur rĂ©Ă©ducation. Ensuite, l’atteinte d’une mĂ©tacognition suffisante pour qu’ils puissent dĂ©velopper des stratĂ©gies qui leurs sont propres et qu’ils sĂ©lectionnent la plus appropriĂ©e dans chaque contexte. Enfin, la facilitation du transfert de ces stratĂ©gies dans la vie quotidienne. Des changements dans l’organisation des thĂ©rapeutes sont Ă©galement attendus
    • 

    corecore